<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04783233</url>
  </required_header>
  <id_info>
    <org_study_id>1685638</org_study_id>
    <nct_id>NCT04783233</nct_id>
  </id_info>
  <brief_title>Chitogel CSK-4 Gel as Packing in Tympanoplasty Surgery</brief_title>
  <official_title>The Use of Chitosan Succinamide (Chitogel CSK-4) Gel as Packing in Tympanoplasty Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ascension South East Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ascension South East Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little innovation in the material used for middle ear packing has occurred over the past&#xD;
      decade, despite the fact that animal models have shown increased acute inflammation and&#xD;
      increased fibrosis in the long term histologically. Although Chitosan Succinamide has shown&#xD;
      improved wound healing and hemostasis in the nasal cavity mucosa, it has yet to be used as a&#xD;
      support material, hemostatic agent, and healing agent in the middle ear. This study will&#xD;
      utilize Chitosan Succinamide as an alternative to purified gelatin foam as a support material&#xD;
      in primary tympanoplasty surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cohort study will be performed. Healthy adults (age &gt; 18) with single tympanic&#xD;
      membrane perforations who have been offered and agreed to undergo tympanoplasty surgery with&#xD;
      fascia graft (either transcanal or post-auricular) will be recruited. The surgical&#xD;
      intervention and procedure of tympanoplasty will be performed as normal, however, the packing&#xD;
      material will be randomly chosen using a random number generator. The middle ear and external&#xD;
      canal will then be packed with either Chitosan Succinamide or Gelfoam. The patients in both&#xD;
      groups will be placed on ciprodex post-operatively for 4 weeks. The patients will be seen&#xD;
      post-operatively at 1 week for photo documentation and removal of the lateral aspect of CS/CD&#xD;
      or Gelfoam. The patients will be seen at 4 weeks for photo documentation and the remainder of&#xD;
      packing removal. At 3 months and 1 year the patients will have photo documentation and an&#xD;
      audiogram.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">January 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>External auditory canal healing</measure>
    <time_frame>Assess healing of auditory canal starting 1 week up to one year following surgery.</time_frame>
    <description>Physician determines exposed bone and inflammatory response</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tympanic membrane healing</measure>
    <time_frame>Assess healing of auditory canal starting 1 week up to one year following surgery.</time_frame>
    <description>Physician determines failed tympanic membrane healing and inflammatory response.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Tympanoplasty Surgery</condition>
  <arm_group>
    <arm_group_label>Packing with Gelfoam</arm_group_label>
    <description>Tympanoplasty surgery with fascia graft (either transcanal or post-auricular) will be preformed. The middle ear and external canal will then be packed with Gelfoam.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Packing with Chitosan succinamide</arm_group_label>
    <description>The surgical intervention and tympanoplasty will be performed as normal. The middle ear and external canal will be packed Chitosan succinamide.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Chitosan succinamide</intervention_name>
    <description>Chitogel will be tested for suitability as a packing material in tympanoplasty surgery.</description>
    <arm_group_label>Packing with Chitosan succinamide</arm_group_label>
    <other_name>Chitogel</other_name>
    <other_name>CSK-4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gelfoam</intervention_name>
    <description>Gelfoam is the current packing material for tympanoplasty surgery.</description>
    <arm_group_label>Packing with Gelfoam</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients eligible for primary tympanoplasty surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults&#xD;
&#xD;
          -  Single tympanic membrane perforation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic recurrent infection or otorrhea&#xD;
&#xD;
          -  Previous ear surgery for the study ear&#xD;
&#xD;
          -  Shellfish allergy&#xD;
&#xD;
          -  Cerebral Spinal Fluid (CSF) leak concern&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brent Wilkerson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician of Record</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brent Wilkerson, M.D.</last_name>
    <phone>(248) 865-4444</phone>
    <email>brentwilkerson1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Conway, DO</last_name>
    <email>conwaydo@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ascension Providence Hospital Novi Campus</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brent Wilkerson, M.D.</last_name>
      <phone>248-865-4444</phone>
      <email>brentwilkerson1@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Valentine R, Athanasiadis T, Moratti S, Hanton L, Robinson S, Wormald PJ. The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery. Am J Rhinol Allergy. 2010 Jan-Feb;24(1):70-5. doi: 10.2500/ajra.2010.24.3422.</citation>
    <PMID>20109331</PMID>
  </reference>
  <reference>
    <citation>Ngoc Ha T, Valentine R, Moratti S, Robinson S, Hanton L, Wormald PJ. A blinded randomized controlled trial evaluating the efficacy of chitosan gel on ostial stenosis following endoscopic sinus surgery. Int Forum Allergy Rhinol. 2013 Jul;3(7):573-80. doi: 10.1002/alr.21136. Epub 2013 Jan 16.</citation>
    <PMID>23322408</PMID>
  </reference>
  <reference>
    <citation>Dogru S, Haholu A, Gungor A, Kucukodaci Z, Cincik H, Ozdemir T, Sen H. Histologic analysis of the effects of three different support materials within rat middle ear. Otolaryngol Head Neck Surg. 2009 Feb;140(2):177-82. doi: 10.1016/j.otohns.2008.10.023.</citation>
    <PMID>19201284</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chitogel</keyword>
  <keyword>Tympanoplasty</keyword>
  <keyword>Support material</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chitosan</mesh_term>
    <mesh_term>Gelatin Sponge, Absorbable</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

